GAL3ST3
Basic information
Region (hg38): 11:66040765-66049161
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAL3ST3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 47 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 6 | |||||
Total | 0 | 0 | 47 | 0 | 12 |
Variants in GAL3ST3
This is a list of pathogenic ClinVar variants found in the GAL3ST3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-66042292-C-T | Benign (Nov 11, 2018) | |||
11-66042404-C-A | Benign (Nov 11, 2018) | |||
11-66042507-T-C | Uncertain significance (Nov 03, 2019) | |||
11-66042550-G-A | not specified | Uncertain significance (Nov 09, 2024) | ||
11-66042557-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
11-66042559-T-C | not specified | Uncertain significance (Feb 05, 2025) | ||
11-66042572-G-T | not specified | Uncertain significance (Jan 24, 2024) | ||
11-66042574-T-G | Benign (Nov 11, 2018) | |||
11-66042577-G-A | not specified | Uncertain significance (Aug 22, 2023) | ||
11-66042578-G-A | not specified | Uncertain significance (Mar 08, 2025) | ||
11-66042580-C-A | not specified | Uncertain significance (Dec 28, 2024) | ||
11-66042581-G-A | not specified | Uncertain significance (Jan 02, 2025) | ||
11-66042593-C-T | not specified | Uncertain significance (Jul 27, 2021) | ||
11-66042596-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
11-66042598-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
11-66042604-T-G | not specified | Uncertain significance (Mar 24, 2023) | ||
11-66042610-T-G | not specified | Uncertain significance (Mar 24, 2023) | ||
11-66042638-C-T | not specified | Uncertain significance (Sep 27, 2024) | ||
11-66042641-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
11-66042689-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
11-66042703-T-C | not specified | Uncertain significance (Dec 15, 2023) | ||
11-66042724-C-G | not specified | Uncertain significance (Dec 14, 2024) | ||
11-66042738-C-T | Benign (Nov 11, 2018) | |||
11-66042768-G-A | Benign (Jun 09, 2021) | |||
11-66042788-C-T | not specified | Uncertain significance (Feb 14, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GAL3ST3 | protein_coding | protein_coding | ENST00000312006 | 2 | 7229 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.93e-8 | 0.0738 | 125474 | 0 | 23 | 125497 | 0.0000916 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.774 | 262 | 300 | 0.874 | 0.0000242 | 2698 |
Missense in Polyphen | 115 | 126.64 | 0.90811 | 1180 | ||
Synonymous | 0.858 | 132 | 145 | 0.909 | 0.0000127 | 943 |
Loss of Function | -0.442 | 11 | 9.53 | 1.15 | 4.09e-7 | 114 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000337 | 0.000332 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000147 | 0.000139 |
European (Non-Finnish) | 0.0000918 | 0.0000882 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000332 | 0.0000327 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transfers a sulfate to position 3 of non-reducing beta- galactosyl residues in N-glycans and core2-branched O-glycans. Has high activity towards Gal-beta-1,4-GlcNAc, Gal-beta-1,4(Fuc-alpha- 1,3)GlcNAc and lower activity towards Gal-beta-1,3(Fuc-alpha- 1,4)GlcNAc. {ECO:0000269|PubMed:11323440, ECO:0000269|PubMed:11356829}.;
- Pathway
- Metapathway biotransformation Phase I and II
(Consensus)
Recessive Scores
- pRec
- 0.110
Haploinsufficiency Scores
- pHI
- 0.156
- hipred
- Y
- hipred_score
- 0.544
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.201
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gal3st3
- Phenotype
Gene ontology
- Biological process
- monosaccharide metabolic process;sulfur compound metabolic process;glycolipid biosynthetic process;oligosaccharide metabolic process;proteoglycan biosynthetic process;poly-N-acetyllactosamine metabolic process
- Cellular component
- integral component of membrane;Golgi cisterna membrane
- Molecular function
- galactosylceramide sulfotransferase activity;carbohydrate binding;3'-phosphoadenosine 5'-phosphosulfate binding;galactose 3-O-sulfotransferase activity;proteoglycan sulfotransferase activity